MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 217 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $28 | -85.2% | 3,871 | -82.3% | 0.00% | -100.0% |
| Q1 2024 | $189 | +47.7% | 21,838 | +11.4% | 0.00% | +100.0% |
| Q4 2023 | $128 | -38.8% | 19,609 | -6.1% | 0.00% | -50.0% |
| Q3 2023 | $209 | -19.6% | 20,879 | -0.3% | 0.00% | 0.0% |
| Q2 2023 | $260 | -18.8% | 20,937 | -8.2% | 0.00% | -33.3% |
| Q1 2023 | $320 | -25.1% | 22,814 | -23.6% | 0.00% | -25.0% |
| Q4 2022 | $427 | -99.9% | 29,874 | +20.3% | 0.00% | -33.3% |
| Q3 2022 | $634,000 | -9.2% | 24,824 | +1.0% | 0.01% | -14.3% |
| Q2 2022 | $698,000 | -21.8% | 24,574 | -3.0% | 0.01% | 0.0% |
| Q1 2022 | $893,000 | -53.4% | 25,327 | -44.7% | 0.01% | 0.0% |
| Q4 2021 | $1,918,000 | +94.9% | 45,792 | +128.4% | 0.01% | -12.5% |
| Q3 2021 | $984,000 | +45.6% | 20,051 | +23.7% | 0.01% | +60.0% |
| Q2 2021 | $676,000 | +69.0% | 16,203 | +44.3% | 0.01% | -66.7% |
| Q1 2021 | $400,000 | – | 11,227 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $269,495,240 | 12.63% |
| 12 West Capital Management LP | 3,361,836 | $41,787,621 | 3.59% |
| Alpine Peaks Capital, LP | 329,424 | $4,094,740 | 2.87% |
| Roubaix Capital, LLC | 235,480 | $2,927,016 | 2.15% |
| Prosight Management, LP | 628,600 | $7,813,498 | 1.17% |
| Cannon Global Investment Management, LLC | 15,800 | $196,394 | 1.02% |
| Curi Wealth Management, LLC | 566,417 | $7,040,564 | 0.95% |
| Mesirow Institutional Investment Management, Inc. | 693,376 | $8,618,664 | 0.89% |
| BRAIDWELL LP | 1,804,700 | $22,432,421 | 0.73% |
| Connacht Asset Management LP | 39,031 | $485,155 | 0.66% |